全文获取类型
收费全文 | 51627篇 |
免费 | 4418篇 |
国内免费 | 3197篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 1260篇 |
妇产科学 | 199篇 |
基础医学 | 4303篇 |
口腔科学 | 337篇 |
临床医学 | 5386篇 |
内科学 | 15908篇 |
皮肤病学 | 265篇 |
神经病学 | 299篇 |
特种医学 | 3159篇 |
外科学 | 9232篇 |
综合类 | 6975篇 |
现状与发展 | 3篇 |
预防医学 | 2046篇 |
眼科学 | 135篇 |
药学 | 4502篇 |
16篇 | |
中国医学 | 2578篇 |
肿瘤学 | 2533篇 |
出版年
2024年 | 62篇 |
2023年 | 830篇 |
2022年 | 1462篇 |
2021年 | 1954篇 |
2020年 | 1947篇 |
2019年 | 1726篇 |
2018年 | 1782篇 |
2017年 | 1724篇 |
2016年 | 1830篇 |
2015年 | 2030篇 |
2014年 | 3443篇 |
2013年 | 3356篇 |
2012年 | 3252篇 |
2011年 | 3390篇 |
2010年 | 3082篇 |
2009年 | 3050篇 |
2008年 | 3154篇 |
2007年 | 3047篇 |
2006年 | 2842篇 |
2005年 | 2353篇 |
2004年 | 1723篇 |
2003年 | 1456篇 |
2002年 | 1334篇 |
2001年 | 1171篇 |
2000年 | 946篇 |
1999年 | 787篇 |
1998年 | 689篇 |
1997年 | 591篇 |
1996年 | 514篇 |
1995年 | 493篇 |
1994年 | 496篇 |
1993年 | 352篇 |
1992年 | 316篇 |
1991年 | 242篇 |
1990年 | 221篇 |
1989年 | 183篇 |
1988年 | 182篇 |
1987年 | 146篇 |
1986年 | 130篇 |
1985年 | 140篇 |
1984年 | 111篇 |
1983年 | 57篇 |
1982年 | 106篇 |
1981年 | 94篇 |
1980年 | 69篇 |
1979年 | 53篇 |
1978年 | 66篇 |
1977年 | 52篇 |
1976年 | 47篇 |
1974年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 141 毫秒
41.
42.
43.
44.
While once considered as incurable systemic disease, treatment options for liver metastases have increased over the last 30 years and safety has improved dramatically, such that for a selected group of patients the hope of cure can now be offered with radical treatment, and low morbidity interventions can be offered which prolong survival, even in patients with more widely disseminated disease. Advances have been made in selection and surgical technique for liver resection and several adjuncts to resection now exist in the form of portal vein embolization, thermal ablation and targeted drug or radiotherapy delivery options. A natural consequence of these developments has been the delivery of services within fewer specialist units, with the result that later complications of therapy may present to local hospitals, rather than directly to the specialist centres. This article will describe the current common liver-directed therapies and outline the presentation and management of their complications. 相似文献
45.
46.
Golo Petzold Melissa Porsche Volker Ellenrieder Steffen Kunsch Albrecht Neesse 《Ultrasound in medicine & biology》2019,45(2):402-410
The aim was to evaluate the influence of food intake on liver stiffness measurement (LSM), performed with 2-D shear wave elastography (Logiq E9, GE Medical Systems, Wauwatosa, WI, USA). One hundred healthy volunteers were prospectively enrolled. Mean age was 25.8 (19–55) y, and mean body mass index was 22.43 (17.3–30.8) kg/m². Patients fasted for at least 3 h and subsequently ingested a liquid meal of 800 kcal. Liver stiffness and portal vein velocity were measured before and after food intake. Food intake resulted in significantly higher LSM values compared with baseline LSM (5.74 ± 0.94 kPa vs. 4.80 ± 0.94 kPa, p < 0.001). On multiple linear regression analysis, body mass index was significantly positively correlated with the LSM increase after food intake (p?=?0.01). No correlation between the increase in LSM and the increase in post-prandial portal vein velocity was observed (r?=?0.09). In summary, food intake has a significant influence on LSM. There is an 11% risk of misclassifying non-fasting, healthy patients as having significant fibrosis. 相似文献
47.
《Journal l'Association canadienne des radiologistes》2019,70(3):226-232
In 2017, the Canadian Association of Radiologists issued a clinical practice guideline (CPG) regarding the use of gadolinium-based contrast agents (GBCAs) in patients with acute kidney injury (AKI), chronic kidney disease (CKD), or on dialysis due to mounting evidence indicating that nephrogenic systemic fibrosis (NSF) occurs with extreme rarity or not at all when using Group II GBCAs or the Group III GBCA gadoxetic acid (compared to first generation Group I linear GBCAs). One of the goals of the work group was to re-evaluate the CPG after 24 months to determine the effect of more liberal use of GBCA on reported cases of NSF in patients with AKI, CKD Stage 4 or 5 (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2), or those that are dialysis-dependent. A comprehensive review of the literature was conducted by a subcommittee of the initial CPG panel between the dates of January 1, 2017-December 31, 2018 to identify new unconfounded cases of NSF linked to Group II or Group III GBCAs and an updated CPG developed. To our knowledge, when using a Group II or Group III GBCA between 2017-2018, only a single unconfounded case report of a fibrosing dermopathy has been reported in a patient who received gadobenate dimeglumine with Stage 2 CKD. No other unconfounded cases of NSF have been reported with Group II or III agents in during this timeframe. The subcommittee concluded that the main recommendations from the 2017 CPG should remain unaltered, but agreed that screening for renal disease in the outpatient setting is no longer justifiable, cost-effective or recommended. Patients on hemodialysis (HD) should, however, be identified prior to GBCA administration to arrange timely HD to optimize gadolinium clearance, although there remains no evidence that HD reduces the risk of NSF. When administering Group II or III GBCAs to patients with AKI, on dialysis or with severe CKD, informed consent relating to NSF is also no longer explicitly recommended. 相似文献
48.
49.
Pregnant women are among the high-risk population for severe coronavirus disease 2019 (COVID-19) with unfavorable peripartum outcomes and increased incidence of preterm births. Hemolysis, the elevation of liver enzymes, and low platelet count (HELLP) syndrome and severe preeclampsia are among the leading causes of maternal mortality. Evidence supports a higher odd of pre-eclampsia in women with COVID-19, given overlapping pathophysiology. Involvement of angiotensin-converting enzyme 2 receptors by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for the entry to the host cells and its downregulation cause dysregulation of the renin-angiotensin-aldosterone system. The overexpression of Angiotensin II mediated via p38 Mitogen-Activated Protein Kinase pathways can cause vasoconstriction and uninhibited platelet aggregation, which may be another common link between COVID-19 and HELLP syndrome. On PubMed search from January 1, 2020, to July 30, 2022, we found 18 studies on of SARS-COV-2 infection with HELLP Syndrome. Most of these studies are case reports or series, did not perform histopathology analysis of the placenta, or measured biomarkers linked to pre-eclampsia/HELLP syndrome. Hence, the relationship between SARS-CoV-2 infection and HELLP syndrome is inconclusive in these studies. We intend to perform a mini-review of the published literature on HELLP syndrome and COVID-19 to test the hypothesis on association vs causation, and gaps in the current evidence and propose an area of future research. 相似文献
50.